retatrutide safety retatrutide clinical trial Investigating the “efficacy and of retatrutide”, Eli Lilly saw " clinically meaningful weight loss” in a phase three ㅤ Go to the C+D website through the link 🔗in the bio 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

This medication, originally developed for managing type 2 diabetes, is now widely prescribed for weight loss due to its ability to regulate appetite and improve blood sugar levels

Both are available through The Care Pharmacys online consultation service for eligible adults

Thiara says patients had to track down doses at far-away pharmacies last year, sometimes driving hours to retrieve a prescription

However, when I stepped on the scale after 30 days, there was no meaningful change in my weight

Damaged nerves stop sending pain signals, leading to problems in the feet, skin infections, ulcerations, and amputation

Retatrutide May Be Preferred For Patients with severe obesity requiring maximum weight loss MASH / fatty liver disease where liver fat reduction is a treatment goal Cases where energy expenditure enhancement could provide additional benefit Patients who have plateaued on dual-agonist therapy Tirzepatide May Be Preferred For Type 2 diabetes with weight management (approved indication) Patients who prioritize an established safety profile Cardiovascular risk populations (pending SURPASS-CVOT data) Settings requiring an FDA-approved, commercially available option The Bottom Line Comparing retatrutide and tirzepatide today is comparing a promising research compound against a proven pharmaceutical